Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2024-07-29 00:00:00 ET · period of report 2024-07-29 · accession 0000950170-24-087381 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-29 | 2024-07-29 | VNDA | Moran Kevin Patrick | SVP, CFO, Treas | S - Sale | $5.92 | -2,251 | 228.8K | -1.0% | -$13.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-29 | S | D | 2,251 | $5.92 | 228,763 | D | — | — |